{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:52:29Z","timestamp":1770738749938,"version":"3.49.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12149-020-01453-y","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T16:03:50Z","timestamp":1583769830000},"page":"337-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-7887","authenticated-orcid":false,"given":"Tanyaluck","family":"Thientunyakit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakmeedaj","family":"Sethanandha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weerasak","family":"Muangpaisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orasa","family":"Chawalparit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuntarat","family":"Arunrungvichian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tossaporn","family":"Siriprapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudthaphon","family":"Vichianin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swatabdi","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaiyawat","family":"Suppasilp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thonnapong","family":"Thongpraparn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rujaporn","family":"Chanachai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juri G.","family":"Gelovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"1453_CR1","first-page":"177","volume":"18","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Zentralbl Nervenh Psych. 1907;18:177\u20139.","journal-title":"Zentralbl Nervenh Psych"},{"issue":"5054","key":"1453_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20136.","journal-title":"Science"},{"key":"1453_CR3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe D. Therapeutics progress and problems on the road to the amyloid hypothesis of Alzheimer\u2019s disease. Science. 2002;297:353\u20136.","journal-title":"Science"},{"issue":"9","key":"1453_CR4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698\u2013712.","journal-title":"Nat Rev Drug Discov"},{"issue":"26","key":"1453_CR5","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.2174\/0929867325666180117094704","volume":"25","author":"A Cistaro","year":"2018","unstructured":"Cistaro A, Alongi P, Caobelli F, Cassalia L. Radiotracers for amyloid imaging in neurodegenerative disease: state-of-the-art and novel concepts. Curr Med Chem. 2018;25(26):3131\u201340.","journal-title":"Curr Med Chem"},{"issue":"6","key":"1453_CR6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet Neurol. 2014;13(6):614\u201329.","journal-title":"The Lancet Neurol"},{"issue":"3","key":"1453_CR7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimer's Dement"},{"issue":"3","key":"1453_CR8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimer's Dement"},{"issue":"8","key":"1453_CR9","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2967\/jnumed.116.187351","volume":"58","author":"S Bullich","year":"2017","unstructured":"Bullich S, Villemagne VL, Catafau AM, Jovalekic A, Koglin N, Rowe CC, et al. Optimal reference region to measure longitudinal amyloid-\u03b2 change with 18F-Florbetaben PET. J Nucl Med. 2017;58(8):1300\u20136.","journal-title":"J Nucl Med"},{"issue":"12","key":"1453_CR10","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med. 2005;46(12):1959\u201372.","journal-title":"J Nucl Med"},{"issue":"7","key":"1453_CR11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","volume":"41","author":"S Landau","year":"2014","unstructured":"Landau S, Thomas B, Thurfjell L, Schmidt M, Margolin R, Mintun M, et al. Amyloid PET imaging in Alzheimer\u2019s disease: a comparison of three radiotracers. Eur J Nucl Med Mol Imaging. 2014;41(7):1398\u2013407.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"20","key":"1453_CR12","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","volume":"89","author":"MJ Grothe","year":"2017","unstructured":"Grothe MJ, Barthel H, Sepulcre J, Dyrba M, Sabri O, Teipel SJ, et al. In vivo staging of regional amyloid deposition. Neurology. 2017;89(20):2031\u20138.","journal-title":"Neurology"},{"issue":"12","key":"1453_CR13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaneurol.2016.3751","volume":"73","author":"M Boccardi","year":"2016","unstructured":"Boccardi M, Altomare D, Ferrari C, Festari C, Guerra UP, Paghera B, et al. Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: the incremental diagnostic value of amyloid PET With [18F]-florbetapir (INDIA-FBP) study. JAMA Neurol. 2016;73(12):1417\u201324.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1453_CR14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JAD-171093","volume":"63","author":"ER Fantoni","year":"2018","unstructured":"Fantoni ER, Chalkidou A, O\u2019Brien JT, Farrar G, Hammers A. A systematic review and aggregated analysis on the impact of amyloid PET brain imaging on the diagnosis, diagnostic confidence, and management of patients being evaluated for Alzheimer\u2019s disease. J Alzheimer's Dis. 2018;63(2):783\u201396.","journal-title":"J Alzheimer's Dis"},{"issue":"7","key":"1453_CR15","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36(7):1238\u201348.","journal-title":"J Nucl Med"},{"issue":"2","key":"1453_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1567205013666160620122346","volume":"14","author":"R Takahashi","year":"2017","unstructured":"Takahashi R, Ishii K, Yokoyama K. Validation of a new imaging technique using the glucose metabolism to amyloid deposition ratio in the diagnosis of Alzheimer\u2019s disease. Curr Alzheimer Res. 2017;14(2):161\u20138.","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"1453_CR17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","volume":"72","author":"SM Landau","year":"2012","unstructured":"Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012;72(4):578\u201386.","journal-title":"Ann Neurol"},{"issue":"12","key":"1453_CR18","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","volume":"35","author":"Y Li","year":"2008","unstructured":"Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2008;35(12):2169\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1453_CR19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.nicl.2017.12.003","volume":"17","author":"L Yan","year":"2018","unstructured":"Yan L, Liu CY, Wong K-P, Huang S-C, Mack WJ, Jann K, et al. Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease. NeuroImage Clin. 2018;17:751\u201360.","journal-title":"NeuroImage Clin"},{"key":"1453_CR20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroimage.2018.04.048","volume":"176","author":"R Marchitelli","year":"2018","unstructured":"Marchitelli R, Aiello M, Cachia A, Quarantelli M, Cavaliere C, Postiglione A, et al. Simultaneous resting-state FDG-PET\/fMRI in Alzheimer Disease: relationship between glucose metabolism and intrinsic activity. NeuroImage. 2018;176:246\u201358.","journal-title":"NeuroImage"},{"key":"1453_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmpb.2016.09.019","volume":"137","author":"I Beheshti","year":"2016","unstructured":"Beheshti I, Demirel H, Farokhian F, Yang C, Matsuda H. Initiative Alzheimer\u2019s Disease Neuroimaging. Structural MRI-based detection of Alzheimer\u2019s disease using feature ranking and classification error. Comput Methods Programs Biomed. 2016;137:177\u201393.","journal-title":"Comput Methods Programs Biomed."},{"key":"1453_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.compbiomed.2017.02.011","volume":"83","author":"I Beheshti","year":"2017","unstructured":"Beheshti I, Demirel H, Matsuda H. Initiative AsDN. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm. Comput Biol Med. 2017;83:109\u201319.","journal-title":"Comput Biol Med."},{"issue":"3","key":"1453_CR23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp-2017-316194","volume":"89","author":"CJ Carswell","year":"2018","unstructured":"Carswell CJ, Win Z, Muckle K, Kennedy A, Waldman A, Dawe G, et al. Clinical utility of amyloid PET imaging with (18) F-florbetapir: a retrospective study of 100 patients. J Neurol Neurosurg Psychiatry. 2018;89(3):294\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1453_CR24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11307-018-1167-1","volume":"20","author":"A Chiaravalloti","year":"2018","unstructured":"Chiaravalloti A, Castellano AE, Ricci M, Barbagallo G, Sannino P, Ursini F, et al. Coupled imaging with [18 F] FBB and [18 F] FDG in AD subjects show a selective association between amyloid burden and cortical dysfunction in the brain. Mol Imaging Biol. 2018;20(4):659\u201366.","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"1453_CR25","first-page":"179","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis: I. Segmentation and surface reconstruction Neuroimage. 1999;9(2):179\u201394.","journal-title":"Segmentation and surface reconstruction Neuroimage"},{"issue":"3","key":"1453_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341\u201355.","journal-title":"Neuron"},{"issue":"3","key":"1453_CR27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3):968\u201380.","journal-title":"Neuroimage"},{"key":"1453_CR28","unstructured":"Initiative AsDN. ADNI-GO PET Technical Procedures Manual AV-45 & FDG. 2011."},{"issue":"7","key":"1453_CR29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jalz.2015.05.001","volume":"11","author":"WJ Jagust","year":"2015","unstructured":"Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, et al. The Alzheimer's disease neuroimaging initiative 2 PET core: 2015. Alzheimer's Dement. 2015;11(7):757\u201371.","journal-title":"Alzheimer's Dement"},{"key":"1453_CR30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","volume":"132","author":"DN Greve","year":"2016","unstructured":"Greve DN, Salat DH, Bowen SL, Izquierdo-Garcia D, Schultz AP, Catana C, et al. Different partial volume correction methods lead to different conclusions: an 18F-FDG-PET study of aging. Neuroimage. 2016;132:334\u201343.","journal-title":"Neuroimage"},{"key":"1453_CR31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","volume":"92","author":"DN Greve","year":"2014","unstructured":"Greve DN, Svarer C, Fisher PM, Feng L, Hansen AE, Baare W, et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage. 2014;92:225\u201336.","journal-title":"Neuroimage"},{"issue":"4","key":"1453_CR32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00004728-199507000-00006","volume":"19","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr. 1995;19(4):541\u20137.","journal-title":"J Comput Assist Tomogr"},{"issue":"4","key":"1453_CR33","first-page":"548","volume":"42","author":"K Ishii","year":"2001","unstructured":"Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, et al. Statistical brain mapping of 18F-FDG PET in Alzheimer\u2019s disease: validation of anatomic standardization for atrophied brains. J Nucl Med. 2001;42(4):548\u201357.","journal-title":"J Nucl Med"},{"key":"1453_CR34","first-page":"661","volume":"45","author":"C TtBF","year":"1993","unstructured":"TtBF C. Thai mental state examination (TMSE). Siriraj Hospital Gazette. 1993;45:661\u201374.","journal-title":"Siriraj Hospital Gazette"},{"key":"1453_CR35","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"J Morris","year":"1993","unstructured":"Morris J. Current vision and scoring rules The Clinical Dementia Rating (CDR). Neurology. 1993;43:2412\u20134.","journal-title":"Neurology"},{"issue":"1","key":"1453_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2377-13-3","volume":"13","author":"V Senanarong","year":"2013","unstructured":"Senanarong V, Harnphadungkit K, Poungvarin N, Vannasaeng S, Chongwisal S, Chakorn T, et al. The dementia and disability project in Thai elderly: rational, design, methodology and early results. BMC Neurol. 2013;13(1):3.","journal-title":"BMC Neurol"},{"issue":"2","key":"1453_CR37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1041610203008822","volume":"15","author":"V Senanarong","year":"2003","unstructured":"Senanarong V, Harnphadungkit K, Prayoonwiwat N, Poungvarin N, Sivasariyanonds N, Printarakul T, et al. A new measurement of activities of daily living for Thai elderly with dementia. Int Psychogeriatr. 2003;15(2):135\u201348.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"1453_CR38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"12","key":"1453_CR39","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308.","journal-title":"Neurology."},{"key":"1453_CR40","doi-asserted-by":"crossref","unstructured":"on Aging TNI, on Diagnostic RIWG, Braak H, Coleman P, Dickson D, Duyckaerts C, et al. Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease. Neurobiol Aging. 1997;18(4):1-2.","DOI":"10.1016\/S0197-4580(97)00057-2"},{"key":"1453_CR41","unstructured":"Lee IA, Preacher KJ. Calculation for the test of the difference between two dependent correlations with one variable in common [Computer software]. 2013. http:\/\/quantpsy.org."},{"issue":"2","key":"1453_CR42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1037\/0033-2909.87.2.245","volume":"87","author":"JH Steiger","year":"1980","unstructured":"Steiger JH. Tests for comparing elements of a correlation matrix. Psychol Bull. 1980;87(2):245.","journal-title":"Psychol Bull"},{"issue":"2","key":"1453_CR43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MNM.0000000000000787","volume":"39","author":"T Thientunyakit","year":"2018","unstructured":"Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, et al. Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer\u2019s disease: first-hand experience in Thailand. Nucl Med Commun. 2018;39(2):186\u201392.","journal-title":"Nucl Med Commun"},{"key":"1453_CR44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmpb.2016.09.019","volume":"137","author":"I Beheshti","year":"2016","unstructured":"Beheshti I, Demirel H, Farokhian F, Yang C, Matsuda H. Alzheimer's Disease Neuroimaging I. Structural MRI-based detection of Alzheimer's disease using feature ranking and classification error. Comput Methods Programs Biomed. 2016;137:177\u201393.","journal-title":"Comput Methods Programs Biomed."},{"key":"1453_CR45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.compbiomed.2017.02.011","volume":"83","author":"I Beheshti","year":"2017","unstructured":"Beheshti I, Demirel H, Matsuda H. Alzheimer's Disease Neuroimaging I. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm. Comput Biol Med. 2017;83:109\u201319.","journal-title":"Comput Biol Med."},{"issue":"3","key":"1453_CR46","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp-2017-316194","volume":"89","author":"CJ Carswell","year":"2018","unstructured":"Carswell CJ, Win Z, Muckle K, Kennedy A, Waldman A, Dawe G, et al. Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients. J Neurol Neurosurg Psychiatry. 2018;89(3):294\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1453_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-018-1167-1","author":"A Chiaravalloti","year":"2018","unstructured":"Chiaravalloti A, Castellano AE, Ricci M, Barbagallo G, Sannino P, Ursini F, et al. Coupled imaging with [(18)F]FBB and [(18)F]FDG in AD subjects show a selective association between amyloid burden and cortical dysfunction in the brain. Mol Imaging Biol. 2018. https:\/\/doi.org\/10.1007\/s11307-018-1167-1.","journal-title":"Mol Imaging Biol"},{"issue":"47","key":"1453_CR48","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","volume":"110","author":"TL Benzinger","year":"2013","unstructured":"Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer\u2019s disease. Proc Natl Acad Sci. 2013;110(47):E4502\u2013E45094509.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"1453_CR49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2967\/jnumed.114.149302","volume":"56","author":"E Klupp","year":"2015","unstructured":"Klupp E, Grimmer T, Tahmasian M, Sorg C, Yakushev I, Yousefi BH, et al. Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions. J Nucl Med. 2015;56(3):399\u2013404.","journal-title":"J Nucl Med"},{"issue":"3","key":"1453_CR50","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","volume":"50","author":"S Minoshima","year":"2001","unstructured":"Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50(3):358\u201365.","journal-title":"Ann Neurol"},{"issue":"1","key":"1453_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/M17-1529","volume":"168","author":"HA Fink","year":"2018","unstructured":"Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med. 2018;168(1):39\u201351.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1453_CR52","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.9778\/cmajo.20150057","volume":"3","author":"D Fitzpatrick-Lewis","year":"2015","unstructured":"Fitzpatrick-Lewis D, Warren R, Ali MU, Sherifali D, Raina P. Treatment for mild cognitive impairment: a systematic review and meta-analysis. CMAJ Open. 2015;3(4):E419.","journal-title":"CMAJ Open"},{"issue":"4","key":"1453_CR53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.bp.113.127811","volume":"203","author":"C Cooper","year":"2013","unstructured":"Cooper C, Li R, Lyketsos C, Livingston G. Treatment for mild cognitive impairment: systematic review. Br J Psychiatry. 2013;203(4):255\u201364.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"1453_CR54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3233\/JAD-180980","volume":"67","author":"D Oezbe","year":"2019","unstructured":"Oezbe D, Graessel E, Donath C, Pendergrass A. Immediate intervention effects of standardized multicomponent group interventions on people with cognitive impairment: a systematic review. J Alzheimer's Dis. 2019;67(2):653\u201370.","journal-title":"J Alzheimer's Dis"},{"issue":"12","key":"1453_CR55","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jagp.2015.07.007","volume":"23","author":"A Str\u00f6hle","year":"2015","unstructured":"Str\u00f6hle A, Schmidt DK, Schultz F, Fricke N, Staden T, Hellweg R, et al. Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: a systematic review and meta-analysis of effects on cognition in randomized controlled trials. Am J Geriatr Psychiatry. 2015;23(12):1234\u201349.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1453_CR56","doi-asserted-by":"crossref","unstructured":"Liang JH, Xu Y, Lin L, Jia RX, Zhang HB, Hang L. Comparison of multiple interventions for older adults with Alzheimer disease or mild cognitive impairment: a PRISMA-compliant network meta-analysis. Medicine. 2018;97(20).","DOI":"10.1097\/MD.0000000000010744"},{"key":"1453_CR57","unstructured":"Kane RL, Butler M, Fink HA, Brasure M, Davila H, Desai P, et al. Interventions to prevent age-related cognitive decline, mild cognitive impairment, and clinical Alzheimer\u2019s-type dementia. Comparative effectiveness reviews, no. 188. Rockville, MD: Agency for Healthcare Research and Quality; 2017."},{"issue":"11","key":"1453_CR58","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12149-019-01397-y","volume":"33","author":"M Kameyama","year":"2019","unstructured":"Kameyama M, Ishibash K, Wagatsuma K, Toyohara J, Ishii K. A pitfall of white matter reference regions used in [18 F] florbetapir PET: a consideration of kinetics. Ann Nucl Med. 2019;33(11):848\u201354.","journal-title":"Ann Nucl Med"},{"key":"1453_CR59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","volume":"4","author":"J Cummings","year":"2018","unstructured":"Cummings J, Lee G, Ritter A, Zhong K. Alzheimer's disease drug development pipeline: 2018. Alzheimer's Dement. 2018;4:195\u201321414.","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"1453_CR60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/joim.12759","volume":"284","author":"R Loera-Valencia","year":"2018","unstructured":"Loera-Valencia R, Piras A, Ismail M, Manchanda S, Eyjolfsdottir H, Saido T, et al. Targeting Alzheimer's disease with gene and cell therapies. J Intern Med. 2018;284(1):2\u201336.","journal-title":"J Intern Med"},{"issue":"4","key":"1453_CR61","first-page":"264","volume":"4","author":"R Doody","year":"2017","unstructured":"Doody R. Developing disease-modifying treatments in alzheimer's disease-a perspective from roche and genentech. J Prev Alzheimer's Dis. 2017;4(4):264\u201372.","journal-title":"J Prev Alzheimer's Dis"},{"issue":"12","key":"1453_CR62","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2967\/jnumed.116.174169","volume":"57","author":"WP Fendler","year":"2016","unstructured":"Fendler WP, Czernin J, Herrmann K, Beyer T. Variations in PET\/MRI operations: results from an international survey among 39 active sites. J Nucl Med. 2016;57(12):2016\u201321.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-020-01453-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T01:05:46Z","timestamp":1615251946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-020-01453-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1453"],"URL":"https:\/\/doi.org\/10.1007\/s12149-020-01453-y","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"10 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}